FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bengt Eriksson

Research Profile

Chemicals & Drugs

Disorders

Procedures

Anatomy

Anterior Cruciate Ligament

Concepts & Ideas

Co-author Network

Publications

TOP 3
Telmo Ramos; Bengt I Eriksson; Jón Karlsson; Lars Nistor
Treatment of distal tibial fractures with the Ilizarov external fixator - a prospective observational study in 39 consecutive patients.
Telmo Ramos; Carl Ekholm; Bengt I Eriksson; Jón Karlsson; Lars Nistor
The Ilizarov external fixator - a useful alternative for the treatment of proximal tibial fractures A prospective observational study of 30 consecutive patients.
Bengt I Eriksson; Stefan Hantel; Andreas Clemens; Ola E Dahl; Nadia Rosencher; Andreas A Kurth
Efficacy of delayed thromboprophylaxis with dabigatran: pooled analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bengt Eriksson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Telmo Ramos; Bengt I Eriksson; Jón Karlsson; Lars Nistor
Treatment of distal tibial fractures with the Ilizarov external fixator - a prospective observational study in 39 consecutive patients.
BMC musculoskeletal disorders 2013;14():30.
2013: Telmo Ramos; Carl Ekholm; Bengt I Eriksson; Jón Karlsson; Lars Nistor
The Ilizarov external fixator - a useful alternative for the treatment of proximal tibial fractures A prospective observational study of 30 consecutive patients.
BMC musculoskeletal disorders 2013;14():11.
2012: Bengt I Eriksson; Stefan Hantel; Andreas Clemens; Ola E Dahl; Nadia Rosencher; Andreas A Kurth
Efficacy of delayed thromboprophylaxis with dabigatran: pooled analysis.
Thrombosis research 2012;130(6):871-6.
2012: M R Lassen; S D Berkowitz; Bengt I Eriksson; M Gent; M Homering; A K Kakkar; A G G Turpie
The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programme.
The Journal of bone and joint surgery. British volume 2012;94(11):1573-8.
2012: Bengt I Eriksson; Martin Feuring; Richard J Friedman; Stefan Hantel; Andreas Clemens; Ola E Dahl; Herbert Noack; Michael Huo
Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: a pooled analysis.
Thrombosis research 2012;130(5):818-20.
2012: Annette Erichsen Andersson; Ingrid Bergh; Bengt I Eriksson; Jón Karlsson; Kerstin Nilsson
Traffic flow in the operating room: an explorative and descriptive study on air quality during orthopedic trauma implant surgery.
American journal of infection control 2012;40(8):750-5.
2012: Bengt I Eriksson; Martin Feuring; Stefan Hantel; Janet Schnee; John J Smith; Joseph Caprini; Andreas Clemens; Gregory W Barsness
Evaluation of the acute coronary syndrome safety profile of dabigatran etexilate in patients undergoing major orthopedic surgery: findings from four Phase 3 trials.
Thrombosis research 2012;130(3):396-402.
2012: Bengt I Eriksson; Richard J Friedman; Martin Homering; Nadia Rosencher; Ola E Dahl
Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty.
Thrombosis research 2012;130(2):147-51.
2012: Ola E Dahl; Andreas A Kurth; Herbert Noack; Nadia Rosencher; Andreas Clemens; Bengt I Eriksson
Thromboprophylaxis in patients older than 75 years or with moderate renal impairment undergoing knee or hip replacement surgery [corrected].
International orthopaedics 2012;36(4):741-8.
2012: Nadia Rosencher; Andreas Clemens; Martin Feuring; Richard J Friedman; Herbert Noack; Bengt I Eriksson
Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials.
Thrombosis journal 2012;10(1):9.
2012: Annette Erichsen Andersson; Ingrid Bergh; Bengt I Eriksson; Jón Karlsson; Kerstin Nilsson
The application of evidence-based measures to reduce surgical site infections during orthopedic surgery - report of a single-center experience in Sweden.
Patient safety in surgery 2012;6(1):11.
2011: Jonas Isberg; Bengt I Eriksson; Eva Faxén; Johan Kärrholm; Gauti Laxdal; Jon Karlsson
Will early reconstruction prevent abnormal kinematics after ACL injury? Two-year follow-up using dynamic radiostereometry in 14 patients operated with hamstring autografts.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 2011;19(10):1634-42.
2011: Bengt I Eriksson; Ola E Dahl; Michael H Huo; Andreas A Kurth; Stefan Hantel; Karin Hermansson; Janet M Schnee; Richard J Friedman
Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
Thrombosis and haemostasis 2011;105(4):721-9.
2011: AG Turpie; Michael R Lassen; Bengt I Eriksson; Michael Gent; Scott Darrell Berkowitz; Frank Misselwitz; Tiemo J Bandel; Martin Homering; Torsten Westermeier; Ajay K Kakkar
Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies.
Thrombosis and haemostasis 2011;105(3):444-53.
2011: Bengt I Eriksson; Daniel J Quinlan; John W Eikelboom
Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism.
Annual review of medicine 2011;62():41-57.
2010: Jeffrey I Weitz; Charlie Cao; Bengt I Eriksson; William Fisher; Stuart Kupfer; Gary E Raskob; Jeffrey Spaeder; Alexander G G Turpie
A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
Thrombosis and haemostasis 2010;104(6):1150-7.
2010: Katarina Nilsson-Helander; Karin Grävare Silbernagel; Roland Thomeé; Eva Faxén; Nicklas Olsson; Bengt I Eriksson; Jon Karlsson
Acute achilles tendon rupture: a randomized, controlled study comparing surgical and nonsurgical treatments using validated outcome measures.
The American journal of sports medicine 2010;38(11):2186-93.
2010: Pia Thomeé; Peter Währborg; Mats Börjesson; Roland Thomeé; Bengt I Eriksson; Jon Karlsson
A randomized, controlled study of a rehabilitation model to improve knee-function self-efficacy with ACL injury.
Journal of sport rehabilitation 2010;19(2):200-13.
2010: Bengt I Eriksson; A G G Turpie; Michael R Lassen; Martin H Prins; Giancarlo Agnelli; Peter Kälebo; G Wetherill; J W Wilpshaar; L Meems
Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2).
Journal of thrombosis and haemostasis : JTH 2010;8(4):714-21.
2010: Karin Grävare Silbernagel; Katarina Nilsson-Helander; Roland Thomeé; Bengt I Eriksson; Jón Karlsson
A new measurement of heel-rise endurance with the ability to detect functional deficits in patients with Achilles tendon rupture.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 2010;18(2):258-64.
2009: Katarina Nilsson-Helander; Anders Thurin; Jon Karlsson; Bengt I Eriksson
High incidence of deep venous thrombosis after Achilles tendon rupture: a prospective study.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 2009;17(10):1234-8.
2009: Bengt I Eriksson; Richard J Friedman
Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2009;15 Suppl 1():25S-31S.
2009: Pia Thomeé; Peter Währborg; Mats Börjesson; Roland Thomeé; Bengt I Eriksson; Jon Karlsson
[Self-belief--basis for successful rehabilitation. Confidence in one's own ability a strong predictor in orthopedic injury].
Läkartidningen 2009;106(32-33):1975-7.
2009: Bengt I Eriksson; A K Kakkar; A G G Turpie; M Gent; T-J Bandel; M Homering; F Misselwitz; M R Lassen
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement.
The Journal of bone and joint surgery. British volume 2009;91(5):636-44.
2009: Sorrel E Wolowacz; Neil S Roskell; Jonathan M Plumb; Joseph A Caprini; Bengt I Eriksson
Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis.
Thrombosis and haemostasis 2009;101(1):77-85.
2008: Wolfgang Mueck; Lars C Borris; Ola E Dahl; Sylvia Haas; Menno V Huisman; Ajay K Kakkar; Peter Kälebo; Eva Muelhofer; Frank Misselwitz; Bengt I Eriksson
Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement.
Thrombosis and haemostasis 2008;100(3):453-61.
2008: Bengt I Eriksson; Richard J Friedman; Fred D Cushner; Michael R Lassen
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.
Clinical orthopaedics and related research 2008;466(8):2009-11; author reply 2012-4.
2008: Ajay K Kakkar; Benjamin Brenner; Ola E Dahl; Bengt I Eriksson; Patrick Mouret; Jim Muntz; Andrea G Soglian; Akos F Pap; Frank Misselwitz; Sylvia Haas
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial.
Lancet 2008;372(9632):31-9.
2008: Bengt I Eriksson; Helen Smith; Uma Yasothan; Peter Kirkpatrick
Dabigatran etexilate.
Nature reviews. Drug discovery 2008;7(7):557-8.
2008: Bengt I Eriksson; Lars C Borris; Richard J Friedman; Sylvia Haas; Menno V Huisman; Ajay K Kakkar; Tiemo J Bandel; Horst Beckmann; Eva Muehlhofer; Frank Misselwitz; William Geerts
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.
The New England journal of medicine 2008;358(26):2765-75.
2008: Katarina Nilsson-Helander; Leif Swärd; Karin Grävare Silbernagel; Roland Thomeé; Bengt I Eriksson; Jon Karlsson
A new surgical method to treat chronic ruptures and reruptures of the Achilles tendon.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 2008;16(6):614-20.
2008: Bengt I Eriksson; Ola E Dahl; Michael R Lassen; D P Ward; R Rothlein; G Davis; A G G Turpie
Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study.
Journal of thrombosis and haemostasis : JTH 2008;6(3):457-63.
2008: Ola E Dahl; Lars C Borris; D Bergqvist; M Schnack Rasmussen; Bengt I Eriksson; A K Kakkar; C W Colwell; Joseph A Caprini; J Fletcher; R J Friedman; Michael R Lassen; Simon P Frostick; M Sakon; L M Kwong; V V Kakkar
Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use.
International angiology : a journal of the International Union of Angiology 2008;27(1):60-7.
2008: Pia Thomeé; Peter Währborg; Mats Börjesson; Roland Thomeé; Bengt I Eriksson; Jon Karlsson
Self-efficacy of knee function as a pre-operative predictor of outcome 1 year after anterior cruciate ligament reconstruction.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 2008;16(2):118-27.
2008: Wolfgang Mueck; Bengt I Eriksson; Kenneth A Bauer; Lars Borris; Ola E Dahl; William D Fisher; Michael Gent; Sylvia Haas; Menno V Huisman; Ajay K Kakkar; Peter Kälebo; Louis M Kwong; Frank Misselwitz; Alexander G G Turpie
Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery.
Clinical pharmacokinetics 2008;47(3):203-16.
2007: Bengt I Eriksson; Ola E Dahl; Nadia Rosencher; A A Kurth; C Niek van Dijk; Simon P Frostick; Peter Kälebo; A V Christiansen; S Hantel; Rohan Hettiarachchi; J Schnee; Harry R Büller
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.
Journal of thrombosis and haemostasis : JTH 2007;5(11):2178-85.
2007: Bengt I Eriksson; Ola E Dahl; Nadia Rosencher; Andreas A Kurth; C Niek van Dijk; Simon P Frostick; Martin H Prins; Rohan Hettiarachchi; Stefan Hantel; Janet Schnee; Harry R Büller
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.
Lancet 2007;370(9591):949-56.
2007: Bengt I Eriksson; Alexander G G Turpie; Michael R Lassen; Martin H Prins; Giancarlo Agnelli; Peter Kälebo; M L Gaillard; L Meems
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery.
Journal of thrombosis and haemostasis : JTH 2007;5(8):1660-5.
2007: Pia Thomeé; Peter Währborg; Mats Börjesson; Roland Thomeé; Bengt I Eriksson; Jon Karlsson
Determinants of self-efficacy in the rehabilitation of patients with anterior cruciate ligament injury.
Journal of rehabilitation medicine : official journal of the UEMS European Board of Physical and Rehabilitation Medicine 2007;39(6):486-92.
2007: Daniel J Quinlan; J W Eikelboom; Ola E Dahl; Bengt I Eriksson; Paul S Sidhu; J Hirsh
Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery.
Journal of thrombosis and haemostasis : JTH 2007;5(7):1438-43.
2007: Sebastian M Schellong; Jan Beyer; Ajay K Kakkar; Kai Halbritter; Bengt I Eriksson; Alexander G G Turpie; Frank Misselwitz; Peter Kälebo
Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study.
Journal of thrombosis and haemostasis : JTH 2007;5(7):1431-7.
2007: William D Fisher; Bengt I Eriksson; Kenneth A Bauer; Lars C Borris; Ola E Dahl; Michael Gent; Sylvia Haas; Martin Homering; Menno V Huisman; Ajay K Kakkar; Peter Kälebo; Louis M Kwong; Frank Misselwitz; Alexander G G Turpie
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.
Thrombosis and haemostasis 2007;97(6):931-7.
2007: Karin Grävare Silbernagel; Roland Thomeé; Bengt I Eriksson; Jon Karlsson
Continued sports activity, using a pain-monitoring model, during rehabilitation in patients with Achilles tendinopathy: a randomized controlled study.
The American journal of sports medicine 2007;35(6):897-906.
2007: Pia Thomeé; Peter Währborg; Mats Börjesson; Roland Thomeé; Bengt I Eriksson; Jon Karlsson
Self-efficacy, symptoms and physical activity in patients with an anterior cruciate ligament injury: a prospective study.
Scandinavian journal of medicine & science in sports 2007;17(3):238-45.
2007: Karin Grävare Silbernagel; Roland Thomeé; Bengt I Eriksson; Jon Karlsson
Full symptomatic recovery does not ensure full recovery of muscle-tendon function in patients with Achilles tendinopathy.
British journal of sports medicine 2007;41(4):276-80; discussion 280.
2007: Katarina Nilsson-Helander; Roland Thomeé; Karin Grävare Silbernagel; Karin Grävare-Silbernagel; Pia Thomeé; Eva Faxén; Bengt I Eriksson; Jon Karlsson
The Achilles tendon Total Rupture Score (ATRS): development and validation.
The American journal of sports medicine 2007;35(3):421-6.
2007: Bengt I Eriksson; Lars C Borris; Ola E Dahl; Sylvia Haas; Menno V Huisman; Ajay K Kakkar; Frank Misselwitz; Eva Muehlhofer; Peter Kälebo
Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement.
Thrombosis research 2007;120(5):685-93.
2006: Bengt I Eriksson; Lars C Borris; Ola E Dahl; Sylvia Haas; Menno V Huisman; Ajay K Kakkar; Eva Muehlhofer; Christoph Dierig; Frank Misselwitz; Peter Kälebo
A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement.
Circulation 2006;114(22):2374-81.
2006: Karl-Heinz Liesenfeld; Hans G Schäfer; Iñaki F Trocóniz; Christiane Tillmann; Bengt I Eriksson; Joachim Stangier
Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis.
British journal of clinical pharmacology 2006;62(5):527-37.
2006: Jonas Isberg; Eva Faxén; Sveinbjörn Brandsson; Bengt I Eriksson; Johan Kärrholm; Jon Karlsson
Early active extension after anterior cruciate ligament reconstruction does not result in increased laxity of the knee.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 2006;14(11):1108-15.
2006: Gauti Laxdal; Jüri Kartus; Bengt I Eriksson; Eva Faxén; Ninni Sernert; Jon Karlsson
Biodegradable and metallic interference screws in anterior cruciate ligament reconstruction surgery using hamstring tendon grafts: prospective randomized study of radiographic results and clinical outcome.
The American journal of sports medicine 2006;34(10):1574-80.
2006: Pia Thomeé; Peter Währborg; Mats Börjesson; Roland Thomeé; Bengt I Eriksson; Jon Karlsson
A new instrument for measuring self-efficacy in patients with an anterior cruciate ligament injury.
Scandinavian journal of medicine & science in sports 2006;16(3):181-7.
2006: Jonas Isberg; Eva Faxèn; Sveinbjörn Brandsson; Bengt I Eriksson; Johan Kärrholm; Jon Karlsson
KT-1000 records smaller side-to-side differences than radiostereometric analysis before and after an ACL reconstruction.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 2006;14(6):529-35.
2006: Ola E Dahl; Mats Ogren; Giancarlo Agnelli; Bengt I Eriksson; Alexander T Cohen; Patrick Mouret; Nadia Rosencher; Anders Bylock; Seva Panfilov; Magnus Andersson
Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty.
Pathophysiology of haemostasis and thrombosis 2006;35(6):428-34.
2006: Bengt I Eriksson; Daniel J Quinlan
Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgery.
Drugs 2006;66(11):1411-29.
2006: Bengt I Eriksson; Lars C Borris; Ola E Dahl; Sylvia Haas; Menno V Huisman; Ajay K Kakkar; Frank Misselwitz; Peter Kälebo
Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement.
Journal of thrombosis and haemostasis : JTH 2006;4(1):121-8.
2005: Theodore E Warkentin; Richard J Cook; Victor J Marder; Jo-Ann I Sheppard; Jane C Moore; Bengt I Eriksson; Andreas Greinacher; John G Kelton
Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.
Blood 2005;106(12):3791-6.
2005: Joachim Stangier; Bengt I Eriksson; Ola E Dahl; Lennart Ahnfelt; Gerhard Nehmiz; Hildegard Stähle; Karin Rathgen; Robbyna Svärd
Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement.
Journal of clinical pharmacology 2005;45(5):555-63.
2005: Ola E Dahl; Bengt I Eriksson; Giancarlo Agnelli; Alexander T Cohen; Patrick Mouret; Nadia Rosencher; Seva Panfilov; Anders Bylock; Magnus Andersson
Postoperative Melagatran/Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic Surgery : Effects of Timing of First Dose and Risk Factors for Thromboembolism and Bleeding Complications on Efficacy and Safety.
Clinical drug investigation 2005;25(1):65-77.
2005: Bengt I Eriksson; Ola E Dahl; Harry R Büller; Rohan Hettiarachchi; Nadia Rosencher; M-L Bravo; Lennart Ahnfelt; Franco Piovella; Joachim Stangier; Peter Kälebo; P Reilly
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.
Journal of thrombosis and haemostasis : JTH 2005;3(1):103-11.
2004: Alexander G G Turpie; Bengt I Eriksson; Kenneth A Bauer; Michael R Lassen
Fondaparinux.
The Journal of the American Academy of Orthopaedic Surgeons 2004;12(6):371-5.
2004: Bengt I Eriksson; Michael R Lassen; Clifford W Colwell
Efficacy of fondaparinux for thromboprophylaxis in hip fracture patients.
The Journal of arthroplasty 2004;19(7 Suppl 2):78-81.
2004: A Y Y Lee; Michael Gent; Jim A Julian; Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen; Alexander G G Turpie
Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic review.
Journal of thrombosis and haemostasis : JTH 2004;2(10):1752-9.
2004: Bengt I Eriksson; Ola E Dahl; Lennart Ahnfelt; Peter Kälebo; Joachim Stangier; Gerhard Nehmiz; K Hermansson; V Kohlbrenner
Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I.
Journal of thrombosis and haemostasis : JTH 2004;2(9):1573-80.
2004: Alexander G G Turpie; Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen
Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points.
Chest 2004;126(2):501-8.
2004: Bengt I Eriksson; Giancarlo Agnelli; Alexander Cohen; Ola Dahl; Patrick Mouret; Nadia Rosencher; Seva Panfilov; Magnus Andersson
Significantly lower need for blood transfusions associated with post-operatively initiated subcutaneous melagatran/oral ximelagatran compared with enoxaparin.
Thrombosis and haemostasis 2004;92(2):428-30.
2004: Bengt I Eriksson; Ola E Dahl
Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitors.
Drugs 2004;64(6):577-95.
2003: Bengt I Eriksson; Giancarlo Agnelli; Alexander T Cohen; Ola E Dahl; Michael R Lassen; Patrick Mouret; Nadia Rosencher; Peter Kälebo; Seva Panfilov; Christina Eskilson; Magnus Andersson; A Freij
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study.
Journal of thrombosis and haemostasis : JTH 2003;1(12):2490-6.
2003: Alexander G G Turpie; Bengt I Eriksson; Kenneth A Bauer; Michael R Lassen
New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies.
Chest 2003;124(6 Suppl):371S-378S.
2003: Alexander G G Turpie; Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
Lancet 2003;362(9395):1582-3.
2003: Alexander G G Turpie; Bengt I Eriksson; Michael R Lassen; Kenneth A Bauer
Fondaparinux, the first selective factor Xa inhibitor.
Current opinion in hematology 2003;10(5):327-32.
2003: Bengt I Eriksson
Improvements in the prevention of postoperative venous thromboembolism in hip fracture patients.
Orthopedics 2003;26(8 Suppl):s851-8.
2003: Bengt I Eriksson
Clinical experience of melagatran/ximelagatran in major orthopaedic surgery.
Thrombosis research 2003;109 Suppl 1():S23-9.
2003: Bengt I Eriksson; Michael R Lassen
Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study.
Archives of internal medicine 2003;163(11):1337-42.
2003: Andreas Greinacher; Petra Eichler; Dorothea Albrecht; Ulrike Strobel; Bernd Pötzsch; Bengt I Eriksson
Antihirudin antibodies following low-dose subcutaneous treatment with desirudin for thrombosis prophylaxis after hip-replacement surgery: incidence and clinical relevance.
Blood 2003;101(7):2617-9.
2003: Bengt I Eriksson; Giancarlo Agnelli; Alexander T Cohen; Ola E Dahl; Patrick Mouret; Nadia Rosencher; Christina Eskilson; Ingela Nylander; Lars Frison; Mats Ogren
Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement.
Thrombosis and haemostasis 2003;89(2):288-96.
2003: Ulf G Eriksson; Jaap W Mandema; Mats O Karlsson; Lars Frison; Per Olsson Gisleskog; Ulrika Wählby; Bengt Hamrén; David Gustafsson; Bengt I Eriksson
Pharmacokinetics of melagatran and the effect on ex vivo coagulation time in orthopaedic surgery patients receiving subcutaneous melagatran and oral ximelagatran: a population model analysis.
Clinical pharmacokinetics 2003;42(7):687-701.
2002: Bengt I Eriksson; David Bergqvist; Peter Kälebo; Ola E Dahl; Siv Lindbratt; Anders Bylock; Lars Frison; Ulf G Eriksson; Lennart Welin; David Gustafsson
Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial.
Lancet 2002;360(9344):1441-7.
2002: Alexander G G Turpie; Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.
Archives of internal medicine 2002;162(16):1833-40.
2002: Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen; Alexander G G Turpie
Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism.
Current opinion in pulmonary medicine 2002;8(5):398-404.
2002: Alexander G G Turpie; Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen
Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.
Lancet 2002;359(9319):1721-6.
2002: Michael Rud Lassen; Kenneth A Bauer; Bengt I Eriksson; Alexander G G Turpie
Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.
Lancet 2002;359(9319):1715-20.
2002: Sveinbjörn Brandsson; Jon Karlsson; Leif Swärd; Jüri Kartus; Bengt I Eriksson; Johan Kärrholm
Kinematics and laxity of the knee joint after anterior cruciate ligament reconstruction: pre- and postoperative radiostereometric studies.
The American journal of sports medicine 2002;30(3):361-7.
2002: Karin Wåhlander; Göran Larson; Tomas L Lindahl; C Andersson; Lars Frison; David Gustafsson; Anders Bylock; Bengt I Eriksson
Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
Thrombosis and haemostasis 2002;87(4):580-5.
2002: Bengt I Eriksson; Mats Ogren; Ulf G Eriksson; Peter Kälebo; Lennart Ahnfelt; Sven Björkström; Ake Sjöstedt; Agnetha Folestad; Ann-Christin Arfwidsson; Christine Sareyko Elvander; Lars Frison
Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement: results from Phase II studies.
Thrombosis research 2002;105(5):371-8.
2002: Bengt I Eriksson; Ann-Christin Arfwidsson; Lars Frison; Ulf G Eriksson; Anders Bylock; Peter Kälebo; Gunnar Fager; David Gustafsson
A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery.
Thrombosis and haemostasis 2002;87(2):231-7.
2002: Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen; Alexander G G Turpie
A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialist.
Journal of the Southern Orthopaedic Association 2002;11(4):197-202.
2002: Alexander G G Turpie; Bengt I Eriksson; Michael R Lassen; Kenneth A Bauer
A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery.
Journal of the Southern Orthopaedic Association 2002;11(4):182-8.
2001: Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen; Alexander G G Turpie
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
The New England journal of medicine 2001;345(18):1305-10.
2001: Bengt I Eriksson; K A Bauer; Michael R Lassen; Alexander G G Turpie
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.
The New England journal of medicine 2001;345(18):1298-304.
2001: Sveinbjörn Brandsson; Jon Karlsson; Bengt I Eriksson; Johan Kärrholm
Kinematics after tear in the anterior cruciate ligament: dynamic bilateral radiostereometric studies in 11 patients.
Acta orthopaedica Scandinavica 2001;72(4):372-8.
2001: Sveinbjörn Brandsson; Eva Faxén; Jüri Kartus; Bengt I Eriksson; Jon Karlsson
Is a knee brace advantageous after anterior cruciate ligament surgery? A prospective, randomised study with a two-year follow-up.
Scandinavian journal of medicine & science in sports 2001;11(2):110-4.
2001: Sveinbjörn Brandsson; Eva Faxén; Jüri Kartus; R Jerre; Bengt I Eriksson; Jon Karlsson
A prospective four- to seven-year follow-up after arthroscopic anterior cruciate ligament reconstruction.
Scandinavian journal of medicine & science in sports 2001;11(1):23-7.
2000: Sveinbjörn Brandsson; Jon Karlsson; P Morberg; B Rydgren; Bengt I Eriksson; T Hedner
Intraarticular morphine after arthroscopic ACL reconstruction: a double-blind placebo-controlled study of 40 patients.
Acta orthopaedica Scandinavica 2000;71(3):280-5.
2000: Sveinbjörn Brandsson; Jüri Kartus; J Larsson; Bengt I Eriksson; Jon Karlsson
A comparison of results in middle-aged and young patients after anterior cruciate ligament reconstruction.
Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association 2000;16(2):178-82.
1999: P Wiger; Sveinbjörn Brandsson; Jüri Kartus; Bengt I Eriksson; Jon Karlsson
A comparison of results after arthroscopic anterior cruciate ligament reconstruction in female and male competitive athletes. A two- to five-year follow-up of 429 patients.
Scandinavian journal of medicine & science in sports 1999;9(5):290-5.
1999: Jüri Kartus; S Lindahl; S Stener; Bengt I Eriksson; Jon Karlsson
Magnetic resonance imaging of the patellar tendon after harvesting its central third: a comparison between traditional and subcutaneous harvesting techniques.
Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association 1999;15(6):587-93.
1999: Jüri Kartus; Lars Ejerhed; Bengt I Eriksson; Jon Karlsson
The localization of the infrapatellar nerves in the anterior knee region with special emphasis on central third patellar tendon harvest: a dissection study on cadaver and amputated specimens.
Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association 1999;15(6):577-86.
1999: Jon Karlsson; Jüri Kartus; Sveinbjörn Brandsson; L Magnusson; Olof Lundin; Bengt I Eriksson
Comparison of arthroscopic one-incision and two-incision techniques for reconstruction of the anterior cruciate ligament.
Scandinavian journal of medicine & science in sports 1999;9(4):233-8.
1999: Sveinbjörn Brandsson; Eva Faxén; Bengt I Eriksson; Leif Swärd; Olof Lundin; Jon Karlsson
Reconstruction of the anterior cruciate ligament: comparison of outside-in and all-inside techniques.
British journal of sports medicine 1999;33(1):42-5.
1999: Ninni Sernert; Jüri Kartus; Kristina Köhler; S Stener; J Larsson; Bengt I Eriksson; Jon Karlsson
Analysis of subjective, objective and functional examination tests after anterior cruciate ligament reconstruction. A follow-up of 527 patients.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 1999;7(3):160-5.
1999: Jon Karlsson; Jüri Kartus; Lennart Magnusson; J Larsson; Sveinbjörn Brandsson; Bengt I Eriksson
Subacute versus delayed reconstruction of the anterior cruciate ligament in the competitive athlete.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 1999;7(3):146-51.
1999: Jüri Kartus; S Lindahl; Kristina Köhler; Ninni Sernert; Bengt I Eriksson; Jon Karlsson
Serial magnetic resonance imaging of the donor site after harvesting the central third of the patellar tendon. A prospective study of 37 patients after arthroscopic anterior cruciate ligament reconstruction.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 1999;7(1):20-4.
1999: Jüri Kartus; Lennart Magnusson; S Stener; Sveinbjörn Brandsson; Bengt I Eriksson; Jon Karlsson
Complications following arthroscopic anterior cruciate ligament reconstruction. A 2-5-year follow-up of 604 patients with special emphasis on anterior knee pain.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 1999;7(1):2-8.
1999: Peter Kälebo; Bengt I Eriksson; B E Zachrisson
Central assessment of bilateral phlebograms in a major multicentre thromboprophylactic trial. Reasons for inadequate results.
Acta radiologica (Stockholm, Sweden : 1987) 1999;40(1):29-32.
1998: Jüri Kartus; S Stener; R Nilsén; U Nilsson; Bengt I Eriksson; Jon Karlsson
Bone mineral assessments in the calcaneus after anterior cruciate ligament injury. An investigation of 92 male patients before and two years after reconstruction or revision surgery.
Scandinavian journal of medicine & science in sports 1998;8(6):449-55.
1998: Jon Karlsson; Bengt I Eriksson; P Renström
Subtalar instability of the foot. A review and results after surgical treatment.
Scandinavian journal of medicine & science in sports 1998;8(4):191-7.
1998: Jüri Kartus; S Stener; S Lindahl; Bengt I Eriksson; Jon Karlsson
Ipsi- or contralateral patellar tendon graft in anterior cruciate ligament revision surgery. A comparison of two methods.
The American journal of sports medicine 1998;26(4):499-504.
1998: Jon Karlsson; Sveinbjörn Brandsson; Peter Kälebo; Bengt I Eriksson
Surgical treatment of concomitant chronic ankle instability and longitudinal rupture of the peroneus brevis tendon.
Scandinavian journal of medicine & science in sports 1998;8(1):42-9.
1998: Sveinbjörn Brandsson; Eva Faxén; Bengt I Eriksson; Peter Kälebo; Leif Swärd; Olof Lundin; Jon Karlsson
Closing patellar tendon defects after anterior cruciate ligament reconstruction: absence of any benefit.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 1998;6(2):82-7.
1997: Bengt I Eriksson; P Wille-Jørgensen; Peter Kälebo; Patrick Mouret; Nadia Rosencher; P Bösch; M Baur; S Ekman; D Bach; Siv Lindbratt; P Close
A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement.
The New England journal of medicine 1997;337(19):1329-35.
1997: Bengt I Eriksson; Stefan Carlsson; M Halvarsson; B Risberg; Christer Mattsson
Antithrombotic effect of two low molecular weight thrombin inhibitors and a low-molecular weight heparin in a caval vein thrombosis model in the rat.
Thrombosis and haemostasis 1997;78(5):1404-7.
1997: Jon Karlsson; Bengt I Eriksson; P A Renström
Subtalar ankle instability. A review.
Sports medicine (Auckland, N.Z.) 1997;24(5):337-46.
1997: Peter Kälebo; B A Anthmyr; Bengt I Eriksson; B E Zachrisson
Optimization of ascending phlebography of the leg for screening of deep vein thrombosis in thromboprophylactic trials.
Acta radiologica (Stockholm, Sweden : 1987) 1997;38(2):320-6.
1997: Bengt I Eriksson; S Ekman; Siv Lindbratt; M Baur; D Bach; C Torholm; Peter Kälebo; P Close
Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.
The Journal of bone and joint surgery. American volume 1997;79(3):326-33.
1997: Jüri Kartus; S Stener; S Lindahl; B Engström; Bengt I Eriksson; Jon Karlsson
Factors affecting donor-site morbidity after anterior cruciate ligament reconstruction using bone-patellar tendon-bone autografts.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 1997;5(4):222-8.
1997: Jüri Kartus; S Stener; Kristina Köhler; Ninni Sernert; Bengt I Eriksson; Jon Karlsson
Is bracing after anterior cruciate ligament reconstruction necessary? A 2-year follow-up of 78 consecutive patients rehabilitated with or without a brace.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 1997;5(3):157-61.
1997: Jon Karlsson; Bengt I Eriksson; T Bergsten; O Rudholm; Leif Swärd
Comparison of two anatomic reconstructions for chronic lateral instability of the ankle joint.
The American journal of sports medicine 1997;25(1):48-53.
1996: Jon Karlsson; Bengt I Eriksson; Leif Swärd
Early functional treatment for acute ligament injuries of the ankle joint.
Scandinavian journal of medicine & science in sports 1996;6(6):341-5.
1996: Peter Kälebo; S Ekman; S Lindbratt; Bengt I Eriksson; U Pauli; B E Zachrisson; P Close
Percentage of inadequate phlebograms and observer agreement in thromboprophylactic multicenter trials using standardized methodology and central assessment.
Thrombosis and haemostasis 1996;76(6):893-6.
1996: Jon Karlsson; Bengt I Eriksson; Leif Swärd
Recurrent dislocation of the peroneal tendons.
Scandinavian journal of medicine & science in sports 1996;6(4):242-6.
1996: Bengt I Eriksson; S Ekman; P Kalebo; B Zachrisson; D Bach; P Close
Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393.
Lancet 1996;347(9002):635-9.
1996: M Magnusson; Bengt I Eriksson; Peter Kälebo; R Sivertsson
Is colour Doppler ultrasound a sensitive screening method in diagnosing deep vein thrombosis after hip surgery?
Thrombosis and haemostasis 1996;75(2):242-5.
1996: Sveinbjörn Brandsson; B Rydgren; T Hedner; Bengt I Eriksson; Olof Lundin; Leif Swärd; Jon Karlsson
Postoperative analgesic effects of an external cooling system and intra-articular bupivacaine/morphine after arthroscopic cruciate ligament surgery.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 1996;4(4):200-5.
1995: Bengt I Eriksson; K Söderberg; L Widlund; B Wandeli; Lilian Tengborn; Bo Risberg
A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers.
Thrombosis and haemostasis 1995;73(3):398-401.
1994: Bengt I Eriksson; Peter Kälebo; S Ekman; S Lindbratt; R Kerry; P Close
Direct thrombin inhibition with Rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement.
Thrombosis and haemostasis 1994;72(2):227-31.
1993: Bengt I Eriksson; Peter Kälebo; Bo Risberg
Clinical experience of a low molecular weight heparin (Fragmin) in the prevention of thromboembolism after total hip replacement.
Seminars in thrombosis and hemostasis 1993;19 Suppl 1():122-7.
1991: Bengt I Eriksson; E Hultman; S Martinell; E Eriksson; Lilian Tengborn; Bo Risberg
Regional fibrinolysis following total hip replacement.
Thrombosis research 1991;62(5):441-7.
1991: Bengt I Eriksson; Peter Kälebo; B A Anthymyr; H Wadenvik; L Tengborn; B Risberg
Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.
The Journal of bone and joint surgery. American volume 1991;73(4):484-93.
1991: Bengt I Eriksson; E Eriksson; Bo Risberg
Impaired fibrinolysis and postoperative thromboembolism in orthopedic patients.
Thrombosis research 1991;62(1-2):55-64.
1990: Peter Kälebo; B A Anthmyr; Bengt I Eriksson; B E Zachrisson
Phlebographic findings in venous thrombosis following total hip replacement.
Acta radiologica (Stockholm, Sweden : 1987) 1990;31(3):259-63.
1989: Bengt I Eriksson; E Eriksson; Erika Gyzander; A C Teger-Nilsson; Bo Risberg
Thrombosis after hip replacement. Relationship to the fibrinolytic system.
Acta orthopaedica Scandinavica 1989;60(2):159-63.
1988: Bengt I Eriksson; B E Zachrisson; A C Teger-Nilsson; Bo Risberg
Thrombosis prophylaxis with low molecular weight heparin in total hip replacement.
The British journal of surgery 1988;75(11):1053-7.